Skip to Content
Get key facts and figures about chronic dry eye

Pemirolast ophthalmic Pregnancy and Breastfeeding Warnings

Pemirolast ophthalmic is also known as: Alamast

Pemirolast ophthalmic Pregnancy Warnings

Pemirolast ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of skeletal abnormalities and dilation of the renal pelvis and ureters in rats given pemirolast at 20,000 times the usual human dose. There are no controlled data in human pregnancy. Pemirolast undergoes low systemic absorption after ocular administration (average plasma concentration: 0.8 ng/mL). Pemirolast ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

See references

Pemirolast ophthalmic Breastfeeding Warnings

There are no data on the excretion of pemirolast ophthalmic into human milk. It is excreted into rat milk at concentrations higher than in plasma. Pemirolast undergoes low systemic absorption after ocular administration (0.8 ng/mL). The manufacturer recommends caution when administering pemirolast ophthalmic to nursing women.

See references

References for pregnancy information

  1. "Product Information. Alamast (pemirolast ophthalmic)" Santen Inc, Napa, CA.

References for breastfeeding information

  1. "Product Information. Alamast (pemirolast ophthalmic)" Santen Inc, Napa, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.